| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 08/03/2006 | US20060173061 New beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173004 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 08/03/2006 | US20060172358 Novel chemiluminescent compounds and their use |
| 08/03/2006 | CA2596548A1 Multiple unit oral sustained release preparation and process for production of the same |
| 08/03/2006 | CA2596237A1 Diamine derivative |
| 08/02/2006 | EP1686118A1 Transesterification process for production of (meth)acrylate ester monomers |
| 08/02/2006 | EP1685132A1 A sb 2B /sb ADENOSINE RECEPTOR ANTAGONISTS |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1685114A2 Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines. |
| 08/02/2006 | EP1685095A1 Method for the production of organic salts containing bis(perfluoroalkyl)phosphinate anions |
| 08/02/2006 | EP1685094A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 08/02/2006 | EP1215206B1 Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof |
| 08/02/2006 | EP1133476B1 Iminoguanidine derivatives, preparation method, use as medicines |
| 08/02/2006 | EP1072576B1 Fluorinating agent, process for producing the same, and use thereof |
| 08/02/2006 | EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/02/2006 | EP0986551B1 Sulfonamide derivatives, their production and use |
| 08/02/2006 | EP0868421B1 Process for the preparation of (meth)acrylic acid esters |
| 08/02/2006 | CN1812978A Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 08/02/2006 | CN1812967A Cathepsin cysteine protease inhibitors |
| 08/02/2006 | CN1810790A Non-metal salt of Glicididazole and its prepn |
| 08/02/2006 | CN1267423C Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists |
| 08/02/2006 | CN1267421C Antiviral activity possessed compound |
| 08/01/2006 | US7084290 Compounds used in batteries, capacitors and galvanic cells |
| 08/01/2006 | US7084278 stereoselective preparation of beta-hydroxy-beta-aryl-beta-heterocyclyl esters, e.g., tert-butyl 3-hydroxy-3-(4-chlorophenyl)-3-(pyridin-2-yl)propionate, by reacting a Reformatsky reagent with a aroylheterocycle (especially a benzoypyridine or a benzoylimidazole) in the presence of a cinchona alkaloid |
| 08/01/2006 | US7084222 Ruthenium complexes, process for preparation thereof, and processes for producing open-ring polymer of cycloolefins and hydrogenation products thereof by using the complex as catalyst |
| 08/01/2006 | US7084208 Textile grafted with bactericide |
| 08/01/2006 | US7084176 N-arylphenylacetamide derivatives and medicinal compositions containing the same |
| 08/01/2006 | US7084166 Such as 1,1-di-(N-benzyl-indol-3-yl)-1-butene; for drug resistant tumors |
| 08/01/2006 | US7084160 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents |
| 08/01/2006 | US7084149 Anticancer agents; antitumor agents |
| 08/01/2006 | US7083928 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives |
| 08/01/2006 | CA2245823C Farnesyl transferase inhibitors |
| 08/01/2006 | CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 08/01/2006 | CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 07/27/2006 | WO2006078775A1 Imidazole and benzimidazole derivatives useful as histamine h3 antagonists |
| 07/27/2006 | WO2006077206A1 New 3-phenylpropionic acid derivatives and their use as ppar- gamma rezeptor liganden |
| 07/27/2006 | WO2006076821A1 2 -c-substituted propane-1, 3 -dicarbonyl compounds and their use in neutralising malodour |
| 07/27/2006 | US20060167269 Compounds and methods for the inhibition of compounds cruzi |
| 07/27/2006 | US20060167267 Michael-type addition of a nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and the conversion of a ester moiety into an amino moiety; S)-2-methylcysteine; desferrithiocin |
| 07/27/2006 | US20060167255 Tetralin and indane derivatives and uses thereof |
| 07/27/2006 | US20060167065 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 07/27/2006 | US20060167014 Piperazine compounds and medicinal use thereof |
| 07/27/2006 | US20060166990 Novel aminobenzophenone compounds |
| 07/27/2006 | US20060166989 2-naphthamide derivatives |
| 07/27/2006 | US20060166858 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals |
| 07/27/2006 | CA2699633A1 Process for producing thiazolidinedione compound and production intermediate thereof |
| 07/27/2006 | CA2595157A1 Imidazole and benzimidazole derivatives useful as histamine h3 antagonists |
| 07/26/2006 | EP1682517A1 Process for the synthesis of imidazoles |
| 07/26/2006 | CN1809538A Cis-2,4,5-triaryl-imidazolines |
| 07/26/2006 | CN1266139C Preparation process of alkyl imidazolidone methacrylate |
| 07/26/2006 | CN1266137C Environmental protection Method for synthesizing room temperature ion liquid |
| 07/26/2006 | CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/26/2006 | CN1265881C High activity metal carbene metathesis catalysts generated using thermally activated N-heterocyclic carbene precursor |
| 07/25/2006 | US7081140 Developer components and their use for dyeing keratinic fibers |
| 07/20/2006 | WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/20/2006 | WO2006076633A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 07/20/2006 | WO2006076509A1 Heterocyclic modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 07/20/2006 | WO2006076202A1 Heterocyclic carboxamide compounds as steroid nuclear receptors ligands |
| 07/20/2006 | WO2006076097A2 Stable non-crystalline formulation comprising losartan |
| 07/20/2006 | WO2006075638A1 Novel heteroaryl derivative |
| 07/20/2006 | WO2006031715A3 Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms) |
| 07/20/2006 | WO2006018846A3 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4h- carbazol-4-one and ondansetron therefrom |
| 07/20/2006 | US20060160894 Benzamides as ppar modulators |
| 07/20/2006 | US20060160864 Acrylamide derivative, process for producing the same, and use |
| 07/20/2006 | US20060160819 Substitued piperazine carbamates |
| 07/20/2006 | US20060160805 Thiotungstate analogues and uses thereof |
| 07/20/2006 | US20060160794 Such as [1-(3,5-bis-trifluoromethylbenzyl)-5-imidazol-1-yl-1H-[1,2,3]triazol-4-yl]-[5-(2-chlorophenyl)-3-hydroxymethyl-isoxazol-4-yl]-methanone; for treatment of depression, anxiety, irritable bowel syndrome, and emesis |
| 07/20/2006 | US20060159618 Preparation of compounds useful for the detection of hypoxia |
| 07/20/2006 | CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/20/2006 | CA2593156A1 Heterocyclic carboxamide compounds as steroid nuclear receptors ligands |
| 07/19/2006 | EP1681290A2 Imidazole derivatives, production method thereof and use thereof |
| 07/19/2006 | EP1680408A2 Ccr3 receptor antagonists |
| 07/19/2006 | EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP0996447B1 Combination therapy for modulating the human sexual response |
| 07/19/2006 | CN1805945A Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
| 07/19/2006 | CN1805915A Indene derivatives as pharmaceutical agents |
| 07/19/2006 | CN1805742A Cis-imidazolines as MDM2 inhibitors |
| 07/19/2006 | CN1803797A Inhibitors of dipeptidyl peptidase IV |
| 07/19/2006 | CN1803775A Method for preparing 5,5-dimethylhydantion |
| 07/19/2006 | CN1264828C Nitric ester and nitrate salts of specific drugs |
| 07/19/2006 | CN1264813C Diphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions |
| 07/19/2006 | CN1264498C Primary intermediates for oxidative coloration of hair |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | US7078529 Imidazole derivatives |
| 07/18/2006 | US7078528 Biimidazole diamide anion binding agents |
| 07/18/2006 | US7078526 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 07/18/2006 | US7078422 Activator for peroxisome proliferator-activated receptor |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/18/2006 | US7078406 using derivatives of 2-(4'-sulfamoylphenyl)-5-(4'-dimethylaminophenyl)oxazoles to monitor a cell environment; improved utility in thermal shift bioassays |
| 07/18/2006 | US7078401 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 07/18/2006 | CA2407416C Alkynyl phenyl heteroaromatic glucokinase activators |
| 07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/13/2006 | WO2006074244A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/13/2006 | WO2006072833A1 Imidazole derivatives as enzyme reverse transcriptase modulators |
| 07/13/2006 | WO2006072775A2 Ionic liquids with a cation comprising a basic moiety |
| 07/13/2006 | WO2006030977A3 Imidazole derivatives as large conductance calcium-activated k channel openers |
| 07/13/2006 | WO2006027705A3 Synthesis of triethylenetetramines |